Nohla Therapeutics Overview
- Founded
- 2015
- Status
- Out of Business
- Employees
- 43
- Latest Deal Type
- Out of Business
Nohla Therapeutics General Information
Description
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical diseases. The company's products are based on a unique umbilical cord blood expansion platform, providing doctors the functional support of bone marrow in response to each patient's unique blood-production needs, without any requirement for HLA matching.
Contact Information
Website
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
- 1600 Fairview Avenue East
- Suite 100
- Seattle, WA 98102
- United States
+1 (206) 000-0000
Nohla Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Out of Business | 01-Nov-2019 | 00000 | Completed | Out of Business | ||
| 4. Early Stage VC (Series B) | 12-Jul-2018 | 0000 | 00000 | Completed | Clinical Trials - Phase 2 | |
| 3. Grant | 28-Sep-2017 | 00.00 | 000.00 | Completed | Startup | |
| 2. Early Stage VC (Series A) | 29-Nov-2016 | $43.5M | $64.5M | 00000 | Completed | Startup |
| 1. Corporate | 24-Dec-2015 | $21M | $21M | Completed | Startup |
Nohla Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 000,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A1 | 000,000,000 | 00.000000 | 00.00 | 00.00 | 00.00 | 00 | 00.00 | 00.00 |
Nohla Therapeutics Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of universal, off-the-shelf cell therapies intended to help treat hematologic malignancies and other critical
Biotechnology
Seattle, WA
43
As of 2018
00000
00000000 00
00000
00 00000
inim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis
0000000000000
Glasgow, United Kingdom
00
As of 0000
000.00
0000
0000-00-00
0000000000 0
000.00
000000 0
dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore ma
0000000000000
Cambridge, MA
000
As of 0000
00000
000000 - 000
00000
Add Comparison
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialNohla Therapeutics Competitors (27)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| TC Biopharm | Venture Capital-Backed | Glasgow, United Kingdom | 00 | 000.00 | 0000000000 0 | 000.00 |
| 000000 00000000000 | Corporation | Cambridge, MA | 000 | 00000 | 000000 - 000 | 00000 |
| 000000000 | Corporate Backed or Acquired | Culver City, CA | 000 | 00000 | 000000&0 | 00000 |
| 00000 0000000000 | Formerly VC-backed | Miramar, FL | 00 | 00000 | 000000&0 | 00000 |
| 000000 | Corporation | Paris, France | 00 | 000.00 | 000000000 | 000.00 |
Nohla Therapeutics Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %ile
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trial